Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)
Titel:
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)
Auteur:
Byrd, John C. Peterson, Bercedis L. Morrison, Vicki A. Park, Kathleen Jacobson, Robert Hoke, Eva Vardiman, James W. Rai, Kanti Schiffer, Charles A. Larson, Richard A.